| Name: |
Biomarker Translation Test (BT Test) |
| Company: |
Provista Life Sciences |
| About the Test: |
The BT Test is a blood test used in the early detection of breast cancer. Breast cancer has a 96-percent survival rate when detected and treated early, yet there is a growing demand from women to create alternative diagnostic screening tools. The BT Test assists physicians in making an earlier and more accurate diagnosis of breast cancer when used adjunctively with a mammogram.
Women ages 35-75 should take the BT Test in conjunction with their annual mammogram. Provista Life Sciences will file private insurance claims on behalf of women who take the BT Test and cover 100 percent of the test's cost not covered by insurance. For women who do not wish to submit an insurance claim, the BT Test is available at a cost of $295.
|
| Functionality: |
The BT Test uses a proprietary algorithm to evaluate the levels and relationship of multiple, cancer-associated protein biomarkers in the blood serum. This data is coupled with a patient's personal medical profile to generate a report. |
| Clinical Trials: |
Extensive clinical trials have been conducted on the BT Test to ensure its efficacy. The studies involved nine clinical sites and a total of approximately 400 women.
|
| Testing Process: |
Physicians are encouraged to discuss the BT Test with their patients during their yearly exam. Once the physician prescribes the test, the woman will fill out a medical history profile. The woman then goes to a Sonora Quest Laboratory for the blood draw. The sample is sent to the laboratory arm of Provista Life Sciences, Provista Diagnostics, to be analyzed. Results are then provided to the doctor for review with the patient.
|
| Results: |
Results are sent in the form of a report, which notes the probability that breast cancer exists in a patient's system. It is recommended that a physician review the report with their patient in order to determine the best course of action based on the test results.
|
| Contact: |
Women and physicians looking to learn more about the BT Test should contact Provista Life Sciences at 602-224-5500.
|